UKHSA - Corporate - Porton Biopharma Limited Valuation
Estimated value
£38k
Awarded value
£38k
Awarded 30 May 2022
Suppliers
1
Lots
1
1 awarded
Published
09 Jun 2022
Deadline 20 May 2022
Description
Financial Valuation for Porton Biopharma Limited for Audit Purposes.
Scope
- Reference
- CF-0845200D0O000000rwimUAA2
- Total value
- £37,500 excluding VAT
- Commercial tool
- Standalone contract
- Contract dates
- 30 May 2022 to 29 Aug 2022
- CPV classifications
- 79410000
Submission & procedure
- Submission deadline
- 20 May 2022, 11:00 am
Award details
Awarded supplier(s), contract period and value as published in the award notice.
Awarded value
£38k
Award date
30 May 2022
Contract start
30 May 2022
Contract end
29 Aug 2022
Awarded to
Awarded suppliers· 1 supplier
Awarded 30 May 2022 · Contract period 30 May 2022 — 29 Aug 2022
Award value
£38k
Other contracts from UK HEALTH AND SECURITY AGENCY
Full notice and award history for this contracting authority is on the buyer profile.
Other contracts awarded to RSM UK CORPORATE FINANCE LLP· 5
Cross-buyer view of this supplier's public-sector wins.
| Title | Type | Value | Published |
|---|---|---|---|
| Aspire Housing Due Diligence | contract | £235k | 11 May 2026 |
| IFRS 16 Modelling for PFI contracts | contract | £60k | 13 Aug 2024 |
| Due Diligence Support for Merger Discussions | contract | £105k | 27 Oct 2023 |
| TROP0023-4 Franchise Financial Advisors | call off | £563k | 24 Dec 2021 |
| GB-Sheffield: External Quality Assurance of Economic Value for Money Models | contract | £54k | 10 Sept 2021 |